Neuronetics, Inc. Deferred Revenue Recognized
Neuronetics, Inc. (STIM) reported Deferred Revenue Recognized of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-11
- Neuronetics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $300.00K, a 0.00% change year-over-year.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $400.00K, a 20.00% decline year-over-year.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $100.00K, a 66.67% decline year-over-year.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $300.00K, a 25.00% decline year-over-year.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $1.00M, a 37.50% decline from fiscal 2024.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $1.60M, a 20.00% decline from fiscal 2023.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $2.00M, a 20.00% decline from fiscal 2022.
- Neuronetics, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $2.50M, a 31.58% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-11 | $700.00K 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-05 | |||||
| 2025-12-31 | $1.00M 10-K · filed 2026-03-17 | |||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-04 | $900.00K 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-11 | $900.00K 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-05 | |||||
| 2024-12-31 | $1.60M 10-K · filed 2026-03-17 | |||||
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-04 | $1.40M 10-Q · filed 2025-11-04 | ||||
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-05 | $1.10M 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | $600.00K 10-Q · filed 2025-05-06 | |||||
| 2023-12-31 | $2.00M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | $0.00 8-K/A · filed 2025-02-06 | $400.00K 10-Q · filed 2023-11-07 | $0.00 8-K/A · filed 2025-02-06 | $1.70M 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $500.00K 10-Q · filed 2024-08-12 | $1.40M 10-Q · filed 2024-08-12 | ||||
| 2023-03-31 | $900.00K 10-Q · filed 2024-05-07 | |||||
| 2022-12-31 | $2.50M 10-K · filed 2024-03-08 | |||||
| 2022-09-30 | $400.00K 10-Q · filed 2023-11-07 | $2.20M 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | $400.00K 10-Q · filed 2022-08-02 | $1.80M 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | $1.40M 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | $1.90M 10-K · filed 2023-03-07 | |||||
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-09 | $1.80M 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | $300.00K 10-Q · filed 2021-08-03 | $1.50M 10-Q · filed 2021-08-03 | ||||
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-12 | |||||
| 2020-12-31 | $2.00M 10-K · filed 2022-03-08 | |||||
| 2020-09-30 | $400.00K 10-Q · filed 2020-11-02 | $1.70M 10-Q · filed 2020-11-02 | ||||
| 2020-06-30 | $400.00K 10-Q · filed 2020-08-04 | $1.30M 10-Q · filed 2020-08-04 | ||||
| 2020-03-31 | $900.00K 10-Q · filed 2020-05-05 | |||||
| 2019-12-31 | $2.20M 10-K · filed 2021-03-02 | |||||
| 2019-09-30 | $2.00M 10-Q · filed 2019-11-05 | |||||
| 2019-06-30 | $1.70M 10-Q · filed 2019-08-06 | |||||
| 2019-03-31 | $1.10M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |